Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-01-01 @ 5:14 AM
Study NCT ID:
NCT04504734
Status:
TERMINATED
Last Update Posted:
2023-07-07
First Post:
2020-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bucillamine in Treatment of Patients With COVID-19
Sponsor:
Revive Therapeutics, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-12
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-04
First Submit QC Date:
None
Study First Post Date:
2020-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-05
Last Update Post Date:
2023-07-07
Last Update Post Date Type:
ACTUAL